u/arne_amankwah

a payment sent on the wrong network is usually gone

Small fix — that is the network fee, not a supplier charge. The distinction matters for the complaint you are making.

Which network, exactly?

Hydration status and fasting state affect the lean mass estimate.

Agreed — and same machine, same conditions, or the two scans are not comparable.

Small fix — external review is independent of the plan. The second-level internal appeal is not.

Confirmation took forty minutes on a busy evening and I had already written half an angry message. Deleted it.

Disagree with the framing. Regain is the documented outcome after discontinuation; calling it a personal failure is both wrong and corrosive.

a1c can be affected by things that have nothing to do with glucose

Keep every transaction hash in a note file with the order reference. It has resolved two queries instantly.

Same. I sat at 0.5mg for three months because it was working and there was nothing to fix.

How many confirmations does it show?

Push back: that is a taper schedule aimed at another member and this board does not host those.

the denial letter names the criterion, start there

week 74 plateau is the most predictable thing in this entire board

Postprandial excursions typically respond earlier than fasting glucose, so the sequence people observe is not a sign that something is not working.

I would not change the programme on the strength of one scan. The measurement error is larger than the effect you are reacting to.

Is this a prior authorisation denial or a formulary exclusion?

janoshik_junkie is right that this is documentation rather than persuasion. It took me a year to accept that.

The transaction hash is the canonical receipt: it is public, verifiable by either party, and it is what a support query should quote.

Got a quote with a fifteen-minute expiry and assumed it was a pressure tactic. It was just a held rate.

A1c reflects average glycaemia over roughly the preceding three months, weighted towards the most recent weeks.

This is the distinction that resolves most of the confusion here — average versus shape.

That criterion is from the previous plan year. The current bulletin has different wording.

A denial letter is required to state a reason and to reference the criterion applied. That reference is the handle: request the clinical policy document by its identifier and answer it point by point.

small trial, big effect, wide error bars

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

The weekly interval comes out of the half-life — roughly a week — so you are on a smooth curve rather than a series of spikes. That is also why moving your day slightly does very little.

That figure is a private price at one pharmacy, not a national one.

That advice is jurisdiction-specific and this board spans several. Say where you are.

Yes — the comparison threads are apples to oranges and they generate more heat than anything else here.

interval stretching is the most commonly described approach here

Did you send a test amount first?

That advice is jurisdiction-specific and this board spans several. Say where you are.

Missed a deadline because I counted from when I opened the envelope. That mistake cost me an entire cycle.

Careful — interval stretching and dose reduction are different interventions and your post uses them interchangeably.

a template letter that quotes their own criteria back is the strongest one

Adding the underused one — external review. Independent, binding where it applies, and hardly anybody gets that far.

Agreed — protein and resistance training. Everything else in these threads is a rounding error on those two.

Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.

Agreed, and the framing that helps is: this is a phase 2 compound with phase 3 running. Everything else is inference.

First month I lost almost nothing and nearly quit. Month two and three were where it all happened.

Agreed. Appetite is the leading indicator and the scale is the lagging one. Watch the first, not the second.

Which phase 2 arm are you quoting, and at what week?